Flourish Research, a multi-site clinical trials company based in Apex, has acquired a California clinical research facility.

From 2019-2023, North Carolina increased the number of life sciences business establishments by 43%. To learn more in the TEConomy 2024 report, click here.

Monroe Biomedical Research (MBR), a dedicated clinical trial site, is growing its footprint to enhance early-phase clinical trials and attract more research opportunities to North Carolina.

Kinvard Bio has been formed through a licensing agreement with Harvard University. Kineticos is licensing research from the ...

IB-T101 demonstrated superior preclinical efficacy in an aggressive renal cell tumor model, significantly outperforming ...

Laura Rowley, Ph.D., vice president of the Life Sciences Economic Development group at the North Carolina Biotechnology ...

Jazz Pharmaceuticals and Chimerix, a Durham-based biotech company, have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total consideration ...

Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical production plant in Lincolnton, N.C., will acquire ...